This collaboration will couple FBL’s competence in manufacturing and customer-driven innovation with AGD’s distribution strength in the US.

The US-Subsidiary company of Indian Fermenta Biotech Limited (FBL), Fermenta Biotech USA LLC (FBU) has acquired 52% stake in a US-based vitamin company AGD Nutrition LLC (AGD), headquartered in Nacogdoches, Texas. With the deal, there will be great operational capabilities for both companies to increase their footprint in the US market as well as work together using their expertise resulting in a great synergy.

This collaboration will enhance FBL’s competence in manufacturing and customer-driven innovation with AGD’s distribution strength in the US, which is geography that commands a significant share of the global human and animal nutrition market. AGD, an established player in the vitamin market since 2002, will be instrumental in paving the way for FBL to gain greater customer access through its deep understanding of the North American market.

Commenting on the development, Mr. Krishna Datla, Managing Director, Fermenta Biotech Ltd. said: “AGD has been our valued partner for many years, and this strategic investment intensifies our longstanding mutually-beneficial relationship in the North American market. We are confident that this alliance will result in increased customer proximity and reaffirm our commitment towards our clientele as a sustainable partner for their nutritional ingredients’ requirements. We look forward to the opportunities that will emerge from this partnership in a way of stronger relationships with customers in the fields of animal nutrition, pharmaceuticals, and dietary supplements.”

Mr. J. Bradley Reynolds, Director, AGD Nutrition LLC commented: “This will be a landmark alliance, where FBL’s technologies and quality product offerings will complement AGD’s relationships with its robust customer base. It marks a milestone in our efforts to achieve sustainable as well as profitable growth and underlines our focus to boost product delivery in the nutritional ingredients segment.”

About Fermenta Biotech Limited (FBL): Fermenta Biotech Ltd. (FBL) is one of the leading manufacturers of Vitamin D3 globally. It caters to over 300 customers across 50 countries with a worldwide distribution network for a variety of applications such as pharmaceuticals, dietary and nutritional supplements, food, animal nutrition, and rodenticides. FBL’s manufacturing facilities in Kullu and Dahej are certified by global accreditations and its world-class R&D center is located at Thane. Apart from Vitamin D3, FBL also possesses expertise in integrated biotechnology solutions such as enzymes for antibiotic synthesis and other niches APIs. For more: http://www.fermentabiotech.com/

About AGD Nutrition LLC: AGD Nutrition LLC (AGD) was founded in 2002 and is shaped by professionals who have managed food and pharmaceutical advancements at leading multinational firms. Currently based out of Texas, AGD possesses expertise in animal nutrition, specifically, ingredients for feed applications. It is also a distinct player in the Food and Dietary Supplements domain across North America. Moreover, AGD commands strong relationships with its clientele, bringing customer proximity along with a wide distribution network across the continent. for more: http://www.agdnutrition.com/

Disclaimer:

The information contained in this article is for educational and informational purposes only and is not intended as a health advice. We would ask you to consult a qualified professional or medical expert to gain additional knowledge before you choose to consume any product or perform any exercise.

Abhinav Mallik
Author

A Journalist who has been working for B2B segment for almost half a decade. He has developed a knack of writing deliberate reports on indigenous market leaders across different sectors like health, fitness and sports goods manufacturing. He developed a discrete interest in covering business reports including business events, expos, and trade fairs.

Write A Comment

two + 10 =

      SUBSCRIBE NEWS LETTER

By navigating our site, you agree to allow us to use cookies, in accordance with our Privacy Policy.